A new research study from the American College of Lifestyle Medicine provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyle‑informed care in primary care settings.Read More
New study demonstrates feasibility and safety of deprescribing diabetes medications when lifestyle medicine is integrated into primary care
By PR Newswire
